Effect of phenytoin on interleukin-1 βproduction in human gingival fibroblasts challenged to tumor necrosis factor a in vitro

European Journal of Oral Sciences

Volumn 104, Issue 1, 1996, Pages 27-33

  Brunius, Gustaf ^a   Yucel Lindberg, Tülay ^a   Shinoda, Keiji ^a   Modeer, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gingival fibroblasts; Interleukin 1 ; Phenytoin; Tumor necrosis factor

Indexed keywords

5 (4 HYDROXYPHENYL) 5 PHENYLHYDANTOIN; DRUG DERIVATIVE; FLURBIPROFEN; INDOMETACIN; INTERLEUKIN 1; PHENYTOIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHILD; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; GINGIVA; GINGIVA HYPERPLASIA; HUMAN; METABOLISM; UPREGULATION;

CHILD; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FIBROBLASTS; FLURBIPROFEN; GINGIVA; GINGIVAL HYPERPLASIA; HUMANS; INDOMETHACIN; INTERLEUKIN-1; PHENYTOIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0030075915     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.1996.tb00042.x     Document Type: Article

References (44)

1. REYNOLDS EH. Chronic antiepileptic toxicity. A review. Epilepsia 1975; 16: 319-352.
2. HASSELL TM. Phenytoin: gingival overgrowth. In Epilepsy and the oral manifestations ofphenytoin therapy, ed. Hassell, TM. 1981; pp. 116-205. Basel : Karger.
3. MODEER T, DAHLLöF G, THEORELL K. Oral health in noninstitutionalized epileptic children with special reference to phenytoin medication. Community Dent Oral Epidemiol 1986; 14: 165-168.
4. NUKI K, COOPER SH. The role of inflammation in the pathogenesis of gingival enlargement during the administration of diphenylhydantoin to cats. J Pcriodont Res 1972; 7: 102-110.
5. DAHLLöF G, MODEER T, REINHOLT FB, WIKSTRöM B, HJERPE A. Proteoglycans and glycosaminoglycans in phenytoin-induced gingival overgrowth. J Periodont Res 1986; 21: IS21.
6. RAO GS, WORTEL JP. Gingival metabolism of phenytoin and covalent binding of its reactive metabolite to gingival proteins in the rat. In Phenytoin-induced teratology and gingival pathology, ed. HASSELL, T.M., Johnston, M.C. & Dudley, K.H. 1980; pp. 189-198, Raven Press, New York.
7. FRITZ S, LINDNER W, ROOTS I, FREY BM, KUPFER A. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans. J Pharmacol Exp Ther 1987; 241: 615-622.
8. BUTLER TC. The metabolic conversion of 5.5-diphenylhydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. J Pharmacol Exp Ther 1957; 119: 1-11.
9. HASSELL TM, PAGE RC. The major metabolite of phenytoin (dilantin) induces gingival overgrowth in cats. J Periodont Res 1978; 13: 280-282.
10. HENDERSON B, BLAKE S. Therapeutic potential of cytokine manipulation. TiPS 1992; 13: 145-152.
11. ROSSOMANDO EF, KENNEDY JE, HADJIMICHAEL J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990; 35: 431-34.
12. WILTON JMA, BAMPTON JML, GRIFFITHS GS, CURTIS MA, LIFE JS, JOHNSON, NW, POWELL JR, HARRAP GJ, CRITCHLEY P. Interleukin-l (IL-I) levels in gingival crevicular fluid from adults with previous evidence of destructive periodontitis. A cross-sectional study. J Clin Periodontol 1992; 19: 53-57.
13. GOWEN M, MUNDY GR. Actions of recombinant interleukin 1, interleukin 2 and interferon-y on bone résorption HI vitro. J Iinnwnol 1986; 136: 2478-2482.
14. LERNER UH, LJUNGGREN 0, DEWHIRST FE, BORASCHI O. Comparison of human interleukin-I and its 163-171 peptide in bone résorption and the immune response. Cytokine 1991; 3: 141-148.
15. RICHARDS D, RUTHERFORD RB. The effects of interleukin 1 on collagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblasts. Arch Oral Biol 1988; 33: 237-243.
16. LERNER UH, MODEER T. Bradykinin B, and B2 receptor agonists synergistically potentiate interleukin-1 induced pros-
17. taglandin biosynthesis in human gingival fibroblasts. Inflammation 1991; 15:427-35.
18. BARTOLD PM. The effect of interleukin-l on hyaluronic acid synthesized by adult human gingival fibroblasts in vitro. J Periodont Res 1988; 23: 139-147.
19. BARTOLD PiM. The effect of interleukin-l on proteoglycans synthesized by human gingival fibroblasts in vitro. Connect Tissue Res 1988; 23: 287-304.
20. LE J, VILCEK J. Tumor necrosis factor and interleukin 1 : cytokines with multiple overlapping activities. Lab Invest 1987; 56: 234-248.
21. CARSWELL EA, OLD LJ, KASSEL RL, GREEN S, FIORE N, WILLIAMSON B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sei USA 1975; 72: 3666-3670.
22. DINARELLO CA,. CANNON JG, WOLFF SM, BERNHEIM HA, BEUTLER B, CERAMI A, FIGARI IS, PALLADINO MA, O'CoNNOR JV. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J ExpMed 1986; 163: 1433-1450.
23. KURT-JONES EA, FIERS W, POSER IS. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol 1987; 139: 2317-2324.
24. LE J, WEINSTEIN D, Gubler U, VILCEK J. Induction of membrane-associated interleukin-1 by tumor necrosis factor in human fibroblasts. J Immunol 1987; 138: 2137-2142.
25. MAUVIEL A, TEMIME N, CHARRON D, LOYAU G, PUJOL J-P. Induction of interleukin-l production in human dermal fibroblasts by interleukin-la and tumor necrosis factor-. Involvement of protein kinase-dependent and adenylate cyclase-dependent regulatory pathways. J Cell Biochem. 1991; 47: 174-183.
26. YucEL-LiNDBERG T, LERNER UH, MODEER T. Effects and interactions of tumour necrosis factor a and bradykinin on interleukin-1 production in gingival fibroblasts. J Periodont Res 1995; 30: 186-191.
27. MODéER T, BRUNIUS G, IINUMA M, LERNER UH Phenytoin potentiates interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts. Br J Pharmacol 1992;106: 574-578.
28. MODEER T, DAHLLöF G, OTTESKOG P. The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro. Acta Odontol Scand 1982; 40: 353-357.
29. BRUNIUS G, IINUMA M, ANDURéN I, LERNER UH, MODéER T. The phenytoin metabolite p-HPPH upregulates prostaglandin biosynhesis in human gingival fibroblasts challenged to interleukin-1. Life Sei 1993; 53: 503-515.
30. MODéER T, ANDURéN I, LERNER UH. Enhanced prostaglandin biosynthesis in human gingival fibroblasts isolated from patients treated with phenytoin. J Oral Pathol Med. 1992; 21: 251-255.
31. ELIAS JA, REYNOLDS MM, KOTLOFF RM, KERN JA. Fibroblast interleukin I: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation. Proc Natl Acad Sei USA 1989; 86: 6171-6175.
32. KRöNKE M, SCHüTZE S, SCHEURICH P, PFIZEN.MAIER K. TNF signal transduction and TNF-responsive genes. Immunol Ser 1992; 56: 189-216.
33. CANDELA M, BARKER SC, BALLOU LR. Sphingosine synergistically stimulates tumor necrosis factor a-induced prostaglandin E2 production in human fibroblasts. J Exp Med 1991; 174: 1363-1369.
34. ISHIDA H, SHINOHARA H, AMABE Y. TOJO H, NAGATA T, WAKANO Y. Effects of interleukin I, tumor necrosis factor a and transforming growth factor on group II phospholipase A2 activity in rat gingival fibroblasts. J Periodont Res 1993; 28: 517-520.
35. KUNKEL SL, CHENSUE SW, PHAN SH. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol, 1986; 136: 186-192.
36. MODEER T, BRUNIUS G, MENDEZ C, JUNTTI-BERGGREN L, BERGGREN P-O. Influence of phenytoin on cytoplasmic free Ca2t level in human gingival fibroblasts. Scand J Dent Res 1991:99:310-315.
37. YAMATO K, EL-HAJJAOUI Z, KOEFFLER HP. Regulation of levels of IL-1 mRNA in human fibroblasts. J Cell Physiol 1989; 139: 610-616.
38. LERNER UH, BRUNIUS G, ANDURéN I, BERGGREN P-O, JUNTTIBERGGREN L, MODEER T. Bradykinin induces a B2 receptormediated calcium signal linked to prostanoid formation in human gingival fibroblasts in vitro. Agents Actions 1992; 37: 44-52.
39. SCHNEIR M, OGATA S, FINE J. Confirmation that neither phenotype nor hydroxylation of collagen is altered in over-
40. grown gingiva from diphenyl hydantoin-treated patients. J Dent Res 1978; 57: 506-510.
41. DAHLLöF G, HJERPE A. Synthesis of sulfated glycosaminoglycans by human gingival fibroblasts from phenytoin-induced gingival overgrowth. Scand J Dent Res 1987; 95: 250-255.
42. KARLINSKY JB, GOLDSTEIN RH. Regulation of sulfated glycosaminoglycan production by prostaglandin E2 in cultured lung fibroblasts. 7 Loft Clin Med 1989; 114: 176-184.
43. FINE A, MATSUI R, ZHAN X, POLIKS CF, SMITH BD, GOLDSTEIN RH. Discordant regulation of human type I collagen genes by prostaglandin E2. Biochim Biophys Acta 1992; 1135: 67-72.
44. Ko SD, PAGE RC, NARAYANAN AS. Fibroblasts heterogeneity and prostaglandin regulation of subpopulations. Proc NatlAcadSci USA 1977; 74: 3429-3432.